Literature DB >> 32342301

Personalized Approach to Determination of Histidine-Rich Glycoprotein and E-Cadherin in Supernatants of Immunocompetent Blood Cells and Breast Biopsy Specimens in Breast Malignant and Non-Malignant Disease.

A I Autenshlyus1,2, A V Bernado3, A A Studenikina3, A V Proskura4, K I Davletova3, I P Zhurakovskiy3,4, S A Arkhipov3,4, N A Varaksin5, S V Sidorov6, V V Lyakhovich4.   

Abstract

The material of patients with invasive carcinoma of no special type (ICNT) and nonmalignant diseases (ND) of the mammary gland was studied. When comparing the concentrations of histidine-rich glycoprotein (HRG) and E-cadherin (CDH1), statistically significant differences between ICNT and ND by HRG in the supernatant of blood cells and its spontaneous production by biopsies and by CDH1 at its induced production, as well as by influence indices of polyclonal activators on the production of CDH1 were found. When comparing the expression of immunohistochemical markers, no statistically significant differences between ICNT and ND were obtained.

Entities:  

Keywords:  breast diseases; cadherin-E; histidine-rich glycoprotein; immunohistochemical markers; proteomics

Year:  2020        PMID： 32342301     DOI： 10.1134/S1607672920010019

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


  8 in total

Review 1.  Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.

Authors:  Hem D Shukla; Javed Mahmood; Zeljko Vujaskovic
Journal:  Cancer Lett       Date:  2015-08-11       Impact factor: 8.679

2.  Effect of autologous platelet-rich plasma on the chondrogenic differentiation of rabbit adipose-derived stem cells in vitro.

Authors:  Xiao-Bo Tang; Pei-Long Dong; Jian Wang; Hai-Yang Zhou; Hai-Xiang Zhang; Shan-Zheng Wang
Journal:  Exp Ther Med       Date:  2015-05-28       Impact factor: 2.447

3.  Extracellular matrix density promotes EMT by weakening cell-cell adhesions.

Authors:  Sandeep Kumar; Alakesh Das; Shamik Sen
Journal:  Mol Biosyst       Date:  2014-01-31

Review 4.  Clinical proteomics and breast cancer.

Authors:  Bashar A Zeidan; Paul A Townsend; Spiros D Garbis; Ellen Copson; Ramsey I Cutress
Journal:  Surgeon       Date:  2015-02-24       Impact factor: 2.392

5.  Personalized Approach to Assessing mRNA Expression of Histidine-Rich Glycoprotein and Immunohistochemical Markers in Diseases of the Breast.

Authors:  A I Autenshlyus; A V Golovanova; A A Studenikina; I I Brusentsov; A V Proskura; I P Zhurakovskiy; S A Arkhipov; S V Sidorov; V A Vavilin; V V Lyakhovich
Journal:  Dokl Biochem Biophys       Date:  2019-04-22       Impact factor: 0.788

6.  Small G protein signalling modulator 2 (SGSM2) is involved in oestrogen receptor-positive breast cancer metastasis through enhancement of migratory cell adhesion via interaction with E-cadherin.

Authors:  Juo-Han Lin; Wen-Jui Lee; Han-Chung Wu; Chih-Hsiung Wu; Li-Ching Chen; Chi-Cheng Huang; Hang-Lung Chang; Tzu-Chun Cheng; Hui-Wen Chang; Chi-Tang Ho; Shih-Hsin Tu; Yuan-Soon Ho
Journal:  Cell Adh Migr       Date:  2019-02-11       Impact factor: 3.405

7.  Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.

Authors:  J Astor Ankney; Ling Xie; John A Wrobel; Li Wang; Xian Chen
Journal:  BMC Med Genomics       Date:  2019-05-30       Impact factor: 3.063

8.  Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior.

Authors:  C D Savci-Heijink; H Halfwerk; G K J Hooijer; J Koster; H M Horlings; S L Meijer; M J van de Vijver
Journal:  Breast Cancer Res Treat       Date:  2019-01-04       Impact factor: 4.872
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.